PL2262503T3 - Preparaty z sangwinaryną, chelerytryną lub chelidoniną do leczenia brodawek, brodawek podeszwowych i łuszczycy plackowatej - Google Patents

Preparaty z sangwinaryną, chelerytryną lub chelidoniną do leczenia brodawek, brodawek podeszwowych i łuszczycy plackowatej

Info

Publication number
PL2262503T3
PL2262503T3 PL09718874T PL09718874T PL2262503T3 PL 2262503 T3 PL2262503 T3 PL 2262503T3 PL 09718874 T PL09718874 T PL 09718874T PL 09718874 T PL09718874 T PL 09718874T PL 2262503 T3 PL2262503 T3 PL 2262503T3
Authority
PL
Poland
Prior art keywords
verrucas
chelidonine
chelerythrine
sanguinarine
warts
Prior art date
Application number
PL09718874T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Paolo Morazzoni
Antonella Riva
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PL2262503T3 publication Critical patent/PL2262503T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Paper (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
PL09718874T 2008-03-10 2009-03-09 Preparaty z sangwinaryną, chelerytryną lub chelidoniną do leczenia brodawek, brodawek podeszwowych i łuszczycy plackowatej PL2262503T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000395A ITMI20080395A1 (it) 2008-03-10 2008-03-10 Formulazioni per il trattamento delle verruche e delle placche psoriatiche
EP09718874.2A EP2262503B1 (en) 2008-03-10 2009-03-09 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
PCT/EP2009/001672 WO2009112226A1 (en) 2008-03-10 2009-03-09 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

Publications (1)

Publication Number Publication Date
PL2262503T3 true PL2262503T3 (pl) 2014-09-30

Family

ID=40292856

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09718874T PL2262503T3 (pl) 2008-03-10 2009-03-09 Preparaty z sangwinaryną, chelerytryną lub chelidoniną do leczenia brodawek, brodawek podeszwowych i łuszczycy plackowatej

Country Status (17)

Country Link
US (2) US8226994B2 (pl)
EP (1) EP2262503B1 (pl)
JP (1) JP5535088B2 (pl)
KR (1) KR20100126367A (pl)
CN (1) CN101959517A (pl)
AU (1) AU2009224936B2 (pl)
CA (1) CA2718384C (pl)
DK (1) DK2262503T3 (pl)
ES (1) ES2467104T3 (pl)
HR (1) HRP20140552T1 (pl)
IL (1) IL208030A (pl)
IT (1) ITMI20080395A1 (pl)
PL (1) PL2262503T3 (pl)
PT (1) PT2262503E (pl)
RU (1) RU2486898C2 (pl)
SI (1) SI2262503T1 (pl)
WO (1) WO2009112226A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
US11566260B2 (en) 2012-07-16 2023-01-31 Universite D'angers Potentiating agents for protecting plants from fungal infections
EP2687097A1 (en) * 2012-07-16 2014-01-22 Universite D'angers Potentiating agents for protecting plants from fungal infections
JP6211380B2 (ja) * 2012-10-17 2017-10-11 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤
KR101431987B1 (ko) * 2013-09-12 2014-08-22 중앙대학교 산학협력단 펠리토린을 유효성분으로 포함하는 접촉성 피부염 개선용 조성물
CN105641576A (zh) * 2014-12-06 2016-06-08 石万桃 一种治疗各种皮肤疣的外用药膏
CN104800216B (zh) * 2015-01-26 2019-03-22 东北师范大学 氯化两面针碱及其衍生物在制备防治皮肤病药物中的应用
IT201600097120A1 (it) * 2016-09-28 2018-03-28 Michele Miglio Formulazione topica per il trattamento della psoriasi
CN116584493A (zh) * 2023-05-18 2023-08-15 东北林业大学 基于白屈菜红碱为主的防治小麦锈病配方及使用方法
CN117064890A (zh) * 2023-09-18 2023-11-17 贵州省天然产物研究中心 盐酸白屈菜红碱在制备治疗银屑病药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590061A (en) * 1983-12-29 1986-05-20 Vipont Laboratories, Inc. Antimicrobial plaque disclosing agent
HU194052B (en) * 1985-03-12 1988-01-28 Caola Kozmetikai Cosmetic composition against verrucae
WO1989005651A1 (en) * 1987-12-23 1989-06-29 Psoricur Ltd. Therapeutical compositions against psoriasis
FR2661330B1 (fr) * 1990-02-07 1995-01-06 Marlene Azoulay Compose permettant des soins de manucure et pedicure et le traitement des cors aux pieds, durillons et verrues.
DE4031960A1 (de) * 1990-10-09 1992-04-16 Dieter Dr Wendorff Pharmazeutische zubereitung zur externen behandlung von schuppenflechte (psoriasis vulgaris)
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US6593371B1 (en) * 1993-05-19 2003-07-15 Jeff J. Staggs Treatment for wart and related disorders
FR2710266B1 (fr) * 1993-09-21 1995-11-17 Paul Dupont Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.
ITMI981542A1 (it) * 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US20020150630A1 (en) * 1999-02-19 2002-10-17 Brooks Norman A. Zinc chloride composition, unit dose packaging, applicator, and method of use in treating cancer and other skin diseases
AU2998900A (en) * 1999-02-19 2000-09-04 Leslee S. Brooks Zinc chloride in treating skin diseases
HU227318B1 (en) * 2000-03-08 2011-03-28 Tibor Bodnar Cosmetical and dematological composition for treating, grooming of psoric skin and scalp
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
DE102005049981A1 (de) * 2005-10-17 2007-04-19 Henkel Kgaa Prickelnde Mundwässer
DE102005060182A1 (de) * 2005-12-14 2007-06-21 Henkel Kgaa Remineralisierende Erzeugnisse
JP2007217410A (ja) * 2006-01-20 2007-08-30 Tsutomu Yoshida 抗ウイルス組成物、それを含む抗ウィルス剤及び抗ウイルス機能性食品
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche

Also Published As

Publication number Publication date
EP2262503B1 (en) 2014-04-30
US20120263810A1 (en) 2012-10-18
AU2009224936A1 (en) 2009-09-17
CA2718384A1 (en) 2009-09-17
ES2467104T3 (es) 2014-06-11
CA2718384C (en) 2016-06-07
US20110014306A1 (en) 2011-01-20
JP2011513449A (ja) 2011-04-28
ITMI20080395A1 (it) 2009-09-11
JP5535088B2 (ja) 2014-07-02
IL208030A (en) 2016-12-29
HRP20140552T1 (hr) 2014-07-18
RU2010137335A (ru) 2012-03-20
US9393280B2 (en) 2016-07-19
DK2262503T3 (da) 2014-05-19
WO2009112226A8 (en) 2009-11-12
WO2009112226A1 (en) 2009-09-17
KR20100126367A (ko) 2010-12-01
SI2262503T1 (sl) 2014-07-31
EP2262503A1 (en) 2010-12-22
IL208030A0 (en) 2010-12-30
CN101959517A (zh) 2011-01-26
RU2486898C2 (ru) 2013-07-10
AU2009224936B2 (en) 2014-11-13
US8226994B2 (en) 2012-07-24
PT2262503E (pt) 2014-06-09

Similar Documents

Publication Publication Date Title
PL2262503T3 (pl) Preparaty z sangwinaryną, chelerytryną lub chelidoniną do leczenia brodawek, brodawek podeszwowych i łuszczycy plackowatej
IL212339A (en) Pyrolobenzodiazepine derivatives and processes for their preparation
IL213070A0 (en) Methods for the treatment of infections and tumors
EP2146717A4 (en) KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYOLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES
EP2348847A4 (en) AZEPINO [4, 5-B] INDOLE AND USE PROCESS
EP2171755A4 (en) Methods for attachment and devices produced using the methods
PL2397158T3 (pl) Skojarzone podawanie związków morfinanów oraz leków przeciwdepresyjnych w leczeniu nietrzymania afektu
SI2245037T1 (sl) Nove spojine in postopki za zdravljenje
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
ZA200908477B (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
SI2066324T1 (sl) Derivati cikloalkanopirolokarbazola in uporaba le-teh kot inhibitorjev parp, vegfr2 in mlk3
WO2009150535A8 (en) Dronedarone for the prevention of permanent atrial fibrillation
IL214348A (en) Use of (-) - trans – 3– (6,5 – dihydro-h4 – pyrrolo [1,2,3 ji] quinoline – 1 – il) –4– (h1– indole – 3 – il) –pyrrolidine – 5, 2 - Deion for the preparation of a drug for the treatment of cancer that is suitable for use with sorfiniv or arlotinib
ZA201004622B (en) Method for increasing the therapeutic efficacy if curcuminoids and analogues
IL210404A0 (en) Combination of a c- met antagonist and an aminoheteroaryl compound for the treatment of cancer
ZA201001262B (en) Interval therapy for the treatment of tinnitus
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
EP2307052A4 (en) ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE
IL195190A (en) 83cd soluble for use in combination therapy with immune suppressant
WO2009103476A8 (en) Antitumoral agents with a benzophenanthridine structure and formulations containing them
WO2009087091A3 (en) Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
AU2009290794A8 (en) Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL208168A0 (en) Tetrahydroisoquinoline derivatives, compositions comprising the same and use thereof
IL206657A0 (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses